IL-13 and IFN-γ: Interactions in lung inflammation

Journal of Immunology

Volumn 167, Issue 3, 2001, Pages 1769-1777

  Ford, J G ^a   Rennick, D ^a   Donaldson, D D ^a   Venkayya, R ^a   McArthur, C ^a   Hansell, E ^a   Kurup, V P ^a   Warnock, M ^a   Grunig G ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 13;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL HYPERPLASIA; CONTROLLED STUDY; EOSINOPHILIA; GOBLET CELL; IMMUNE RESPONSE; LUNG LAVAGE; MOUSE; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; TH1 CELL; TH2 CELL;

EID: 0035424808     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.3.1769     Document Type: Article

References (68)

1. Current estimates from the National Health Interview Survey, 1995
2. Race, asthma, and persistent wheeze in Philadelphia schoolchildren
3. Immunologic basis of antigen-induced airway hyperresponsiveness
4. Complexity and redundancy in the pathogenesis of asthma: Reassessing the roles of mast cells and T cells
5. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity
6. Role of IL-5 in the development of allergen-induced airway hyperresponsiveness
7. Interleukin-13: Central mediator of allergic asthma
8. Requirement for IL-13 independently of IL-4 in experimental asthma
9. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
10. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness
11. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics
12. Mechanisms of persistent airway inflammation in asthma: A role for T cells and T-cell products
13. T cells and chronic asthma
14. The one-two of T helper cells: Does interferon-γ knock out the Th2 hypothesis for asthma?
15. T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma
16. Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergen challenge
17. Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma
18. Could asthma be worsened by stimulating the T-helper type I immune response?
19. Th2 cells and GATA-3 in asthma: New insights into the regulation of airway inflammation
20. Could the risk of asthma and atopy be reduced by a vaccine that induces a strong T-helper type I response?
21. + cells adoptively transfer experimental hypersensitivity pneumonitis
22. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation
23. Modulation of airway inflammation by passive transfer of allergen- specific Th1 and Th2 cells in a mouse model of asthma
24. Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation
25. Mechanisms preventing allergen-induced airways hyperreactivity: Role of tolerance and immune deviation
26. T-cell cytokine pattern at three time points during specific immunotherapy for mite-sensitive asthma
27. Allergen-specific production of interferon-γ by peripheral blood mononuclear cells and CD8 T cells in allergic disease and following immunotherapy
28. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response
29. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
30. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE
31. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis
32. The murine IL-13 receptor α2: Molecular cloning, characterization, and comparison with murine IL-13 receptor α1
33. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice
34. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
35. + T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype
36. + T cells
37. Mice lacking the IFN-γ receptor have impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile
38. Mucosal IFN-γ gene transfer inhibits pulmonary allergic responses in mice
39. Role of IFN-γ in the inhibition of the allergic airway inflammation caused by 1L-12
40. Allergen immunotherapy inhibits airway eosinophilia and hyperresponsiveness associated with decreased IL-4 production by lymphocytes in a murine model of allergic asthma
41. Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity
42. T helper 1 cells and interferon γ regulate allergic airway inflammation and mucus production
43. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice
44. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice
45. Resistance to antigen-induced airway hyperresponsiveness requires endogenous production of IL-12
46. Systemic and local interferon γ gene delivery to the lungs for treatment of allergen-induced airway hyperresponsiveness in mice
47. Inhibitory effects of endogenous and exogenous interferon-γ on bronchial hyperresponsiveness, allergic inflammation and T-helper 2 cytokines in Brown-Norway rats
48. Vaccination with allergen-IL-18 fusion DNA protects against, and reverses established, airway hyperreactivity in a murine asthma model
49. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity
50. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema
51. IL-13-mediated worm expulsion is B7 independent and IFN-γ sensitive
52. IFN-γ and IL-10 inhibit induction of IL-1 receptor type I and type II gene expression by IL-4 and IL-13 in human monocytes
53. The human IgE germline promoter is regulated by interleukin-4, interleukin-13, interferon-α and interferon-γ via an interferon-γ-activated site and its flanking regions
54. + dendritic cell traffic to the lung
55. Th2-type cytokines modulate IL-6 release by human bronchial epithelial cells
56. Modulation of murine macrophage function by IL-13
57. + T cells
58. Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation
59. Differentiation of human NK cells into NK1 and NK2 subsets
60. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice
61. IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation
62. + T cells in a transfer model of colitis
63. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4
64. Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model
65. Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics
66. Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression
67. Development of airway hyperresponsiveness is dependent on interferon-γ and independent of eosinophil infiltration
68. Differential effects of endogenous and exogenous Interferon-γ on immunoglobulin E, cellular infiltration, and airway responsiveness in a murine model of allergic asthma